Clinical trial
Phase I Study Evaluating the Treatment of Patients With Hepatocellular Carcinoma (HCC) With Carbon Ion Radiotherapy
NCT01167374 is registered in ClinicalTrials.gov with University Hospital Heidelberg as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase I Study Evaluating the Treatment of Patients With Hepatocellular Carcinoma (HCC) With Carbon Ion Radiotherapy
- Lead sponsor
- University Hospital Heidelberg
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- August 31, 2011
- Completion date
- August 31, 2022
- Enrollment
- 21 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hepatocellular carcinoma